Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Cytokinetics inches forward with heart failure program
BioPharma Dive
Thu, 08/3/17 - 10:57 am
Tags:
Cytokinetics, Omecamtiv Mecarbil, Amgen, heart failure, Japan
As Roche wades biosimilar waters, more competitors circle Herceptin
BioPharma Dive
Wed, 08/2/17 - 09:28 pm
Tags:
Roche, Herceptin, biosimilars, Amgen, Allergan, ABP 980, Celltrion, CT-P6
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Fierce Pharma
Mon, 07/31/17 - 09:56 pm
Tags:
FDA, Herceptin, biosimilars, Roche, Amgen, Teva Pharmaceutical, Allergan, Celltrion
With $39B in cash and biosim threats looming, could Amgen use a deal? Executives say not yet
Fierce Pharma
Wed, 07/26/17 - 10:36 pm
Tags:
Amgen, biosimilars, M&A
Amgen second-quarter profit tops Street view, shares fall
Reuters
Wed, 07/26/17 - 09:54 am
Tags:
Amgen, earnings
Amgen And Novartis: First Mover Advantage Is A Must
Seeking Alpha
Mon, 07/24/17 - 11:55 pm
Tags:
Amgen, Novartis, migraines, erenumab, CGRP blockers
Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN
Yahoo/Zacks.com
Mon, 07/24/17 - 11:14 am
Tags:
earnings, Eli Lilly, Biogen, Amgen
An Endocrinologist Explains Her View Of Tymlos And The Osteoporosis Landscape
Seeking Alpha
Mon, 07/24/17 - 10:44 am
Tags:
Amgen, Radius Health, osteoporosis, Tymlos, romosozumab
Drugmakers face challenges marketing new heart drugs
Medical Marketing and Media
Sat, 07/22/17 - 10:01 am
Tags:
drug marketing, Amgen, Repatha, Novartis, Entresto, Ilaris, canakinumab, Merck, Anacetrapib
Amgen and Novartis ID the finish line in a wicked scramble for first CGRP migraine drug OK
Endpoints
Thu, 07/20/17 - 11:34 pm
Tags:
Amgen, Novartis, migraines, CGRPs, Aimovig
FDA rejects Amgen’s osteoporosis drug romo as rival Radius surprises with a new CEO
Endpoints
Mon, 07/17/17 - 09:15 am
Tags:
FDA, Amgen, osteoporosis, romosozumab, UCB Pharma, Radius Health, Tymlos
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Fri, 07/14/17 - 07:58 am
Tags:
Novartis, rheumatoid arthritis, generics, Sandoz, Amgen, Enbrel, JNJ, Remicade, AbbVie, Humira
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Fierce Pharma
Fri, 07/14/17 - 07:54 am
Tags:
Amgen, Kyprolis, Revlimid, Celgene, Takeda, Velcade, Multiple Myeloma
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
Endpoints
Wed, 07/12/17 - 10:36 am
Tags:
Roche, biosimilars, Avastin, Herceptin, ABP 215, Amgen, MYL-14010, Mylan Labs, Rituxan
Amgen, Teva hikes show pharma can't blame rebates for all price increases: analyst
Fierce Pharma
Thu, 07/6/17 - 11:22 pm
Tags:
Amgen, Teva Pharmaceutical, rebates, drug pricing
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Endpoints
Wed, 07/5/17 - 09:37 am
Tags:
Coherus, Amgen, biosimilars, Daiichi Sankyo, CHS-0214, rheumatoid arthritis, Enbrel
Two cancer drug prices have already been hiked by 8% this year
Marketwatch
Wed, 07/5/17 - 09:35 am
Tags:
drug pricing, cancer, Amgen, Blincyto, Teva Pharmaceutical, Treanda, lymphoma, leukemia
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
Tags:
prescription data, Sanofi, Lantus, Roche, Herceptin, Avastin, Celgene, Revlimid, JNJ, Merck, Remicade, Biogen, Rituxan, Amgen, Enbrel, Gilead Sciences, Harvoni, AbbVie, Humira
Coherus cuts staff after FDA red light
BioPharma Dive
Wed, 06/28/17 - 10:52 pm
Tags:
Coherus Biosciences, layoffs, FDA, biosimilars, Amgen, Neulasta
FDA Rejects Pfizer's Anemia Drug Biosimilar
Xtalks
Tue, 06/27/17 - 11:50 pm
Tags:
FDA, Pfizer, biosimilars, Epogen, Amgen, anemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.